Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 6
1946 18
1947 17
1948 11
1949 7
1950 15
1951 15
1952 12
1953 31
1954 73
1955 71
1956 107
1957 110
1958 125
1959 125
1960 224
1961 260
1962 480
1963 806
1964 1256
1965 975
1966 1006
1967 1256
1968 1739
1969 2293
1970 2495
1971 2702
1972 2676
1973 2873
1974 2891
1975 2863
1976 2655
1977 2656
1978 2664
1979 2900
1980 2786
1981 3025
1982 3365
1983 3572
1984 4118
1985 4436
1986 4423
1987 4954
1988 5214
1989 5528
1990 5507
1991 5810
1992 5993
1993 6092
1994 6388
1995 6630
1996 7056
1997 6611
1998 7132
1999 7094
2000 7616
2001 8040
2002 8249
2003 8773
2004 9221
2005 10273
2006 10554
2007 10928
2008 11229
2009 11978
2010 12347
2011 13053
2012 13512
2013 13493
2014 13559
2015 13211
2016 12815
2017 12233
2018 11932
2019 11963
2020 12663
2021 11481
2022 10373
2023 9573
2024 9726
2025 4841

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

395,097 results

Results by year

Filters applied: . Clear all
Page 1
Immunosuppressive drugs modes of action.
Meneghini M, Bestard O, Grinyo JM. Meneghini M, et al. Best Pract Res Clin Gastroenterol. 2021 Oct-Dec;54-55:101757. doi: 10.1016/j.bpg.2021.101757. Epub 2021 Jun 16. Best Pract Res Clin Gastroenterol. 2021. PMID: 34874841 Free article. Review.
At the intracellular level, the inflammatory cascade is mediated by multifaceted processes that have been better described in the last 10 years. Immunosuppressive agents available in clinical practice act at different points of those cascades at the intracellular or …
At the intracellular level, the inflammatory cascade is mediated by multifaceted processes that have been better described in the last 10 ye …
Immunosuppression and Kidney Transplantation.
Kamal J, Doyle A. Kamal J, et al. Handb Exp Pharmacol. 2022;272:165-179. doi: 10.1007/164_2021_546. Handb Exp Pharmacol. 2022. PMID: 34697664 Review.
Immunosuppression is complex, fraught with on-target and off-target adverse effects, and hard to get right but is the key to successful allotransplantation. Herein, we review the key immunosuppressive agent classes used for kidney transplant, highlighting mechanisms …
Immunosuppression is complex, fraught with on-target and off-target adverse effects, and hard to get right but is the key to successful allo …
Cyclophosphamide and cancer: golden anniversary.
Emadi A, Jones RJ, Brodsky RA. Emadi A, et al. Nat Rev Clin Oncol. 2009 Nov;6(11):638-47. doi: 10.1038/nrclinonc.2009.146. Epub 2009 Sep 29. Nat Rev Clin Oncol. 2009. PMID: 19786984 Review.
Cyclophosphamide remains one of the most successful and widely utilized antineoplastic drugs. Moreover, it is also a potent immunosuppressive agent and the most commonly used drug in blood and marrow transplantation (BMT). ...Differential cellular expression of alde …
Cyclophosphamide remains one of the most successful and widely utilized antineoplastic drugs. Moreover, it is also a potent immunosuppres …
Tacrolimus: a new immunosuppressive agent.
Kelly PA, Burckart GJ, Venkataramanan R. Kelly PA, et al. Am J Health Syst Pharm. 1995 Jul 15;52(14):1521-35. doi: 10.1093/ajhp/52.14.1521. Am J Health Syst Pharm. 1995. PMID: 7552894 Review.
Sirolimus: its discovery, biological properties, and mechanism of action.
Sehgal SN. Sehgal SN. Transplant Proc. 2003 May;35(3 Suppl):7S-14S. doi: 10.1016/s0041-1345(03)00211-2. Transplant Proc. 2003. PMID: 12742462 Review.
Although sirolimus was isolated as an antifungal agent with potent anticandida activity, subsequent studies revealed impressive antitumor and immunosuppressive activities. ...Interest in sirolimus as an immunosuppressive therapy in organ transplantation deriv …
Although sirolimus was isolated as an antifungal agent with potent anticandida activity, subsequent studies revealed impressive antit …
CTLA4-Ig: a novel immunosuppressive agent.
Najafian N, Sayegh MH. Najafian N, et al. Expert Opin Investig Drugs. 2000 Sep;9(9):2147-57. doi: 10.1517/13543784.9.9.2147. Expert Opin Investig Drugs. 2000. PMID: 11060799 Review.
Large clinical randomised trials on the use of CTLA4-Ig are missing, nevertheless, its immunosuppressive effects coupled with features such as specificity of interaction and low toxicity, make CTLA4-Ig a promising new therapeutic agent for induction of donor-specifi …
Large clinical randomised trials on the use of CTLA4-Ig are missing, nevertheless, its immunosuppressive effects coupled with feature …
Everolimus: an immunosuppressive agent in transplantation.
Patel JK, Kobashigawa JA. Patel JK, et al. Expert Opin Pharmacother. 2006 Jul;7(10):1347-55. doi: 10.1517/14656566.7.10.1347. Expert Opin Pharmacother. 2006. PMID: 16805720 Review.
Everolimus is a novel immunosuppressive agent related to sirolimus. It is a proliferation signal inhibitor with an improved pharmacokinetic profile and bioavailability compared with sirolimus. ...
Everolimus is a novel immunosuppressive agent related to sirolimus. It is a proliferation signal inhibitor with an improved ph …
395,097 results
You have reached the last available page of results. Please see the User Guide for more information.